COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
BIOPHYTIS ANNOUNCES COMPLETION OF OVER €2.0 MILLION CAPITAL INCREASE AND THE REPAYMENT OF ALL VARIABLE PRICE CONVERTIBLE DEBT
Biophytis completes a €2.0 million capital increase, repays variable price convertible debt, and plans to focus on clinical development in sarcopenia and obesity. Key investors include Alumni Capital Management, Bigger Capital, and Hexagon Capital Fund -
-
-
-
-
-
-
COMMUNIQUÉ RÉGLEMENTÉ
BIOPHYTIS ANNOUNCES COMPLETION OF OVER €2.0 MILLION CAPITAL INCREASE AND THE REPAYMENT OF ALL VARIABLE PRICE CONVERTIBLE DEBT
Biophytis completes over €2.0 million capital increase and repays all variable price convertible debt, attracting investments from U.S. healthcare institutions and strengthening financial structure for clinical development in sarcopenia and obesity -
COMMUNIQUÉ RÉGLEMENTÉ
BIOPHYTIS ANNONCE LA REALISATION D’UNE LEVEE DE FONDS DE PLUS DE 2 MILLIONS D’EUROS ET LE REMBOURSEMENT DE L’INTEGRALITE DE SA DETTE CONVERTIBLE A PRIX VARIABLE
Biophytis annonce l'augmentation de capital de plus de 2 millions d'euros, le remboursement de dettes et l'utilisation des fonds levés pour la recherche médicale et les partenariats
